These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32347068)

  • 21. Serum Protein Fishing for Machine Learning-Boosted Diagnostic Classification of Small Nodules of Lung.
    Wang M; Dai X; Yang X; Jin B; Xie Y; Xu C; Liu Q; Wang L; Ying L; Lu W; Chen Q; Fu T; Su D; Liu Y; Tan W
    ACS Nano; 2024 Feb; 18(5):4038-4055. PubMed ID: 38270088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer.
    Jiang LP; Zhu ZT; He CY
    Future Oncol; 2016 May; 12(9):1105-15. PubMed ID: 27033050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Diagnostic Gene Biomarkers for Non-Small-Cell Lung Cancer.
    Liang B; Shao Y; Long F; Jiang SJ
    Biomed Res Int; 2016; 2016():3952494. PubMed ID: 27579312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
    Du ZY; Shi MH; Ji CH; Yu Y
    Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of KIF23 and Its Prognostic Role in Non-small Cell Lung Cancer: 
Analysis Based on the Data-mining of Oncomine].
    Ye L; Li H; Zhang F; Lv T; Liu H; Song Y
    Zhongguo Fei Ai Za Zhi; 2017 Dec; 20(12):822-826. PubMed ID: 29277180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Machine Learning Modeling to Explore New Immune-Related Prognostic Markers in Non-Small Cell Lung Cancer.
    Xu J; Nie H; He J; Wang X; Liao K; Tu L; Xiong Z
    Front Oncol; 2020; 10():550002. PubMed ID: 33215029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer.
    Zhou R; Zhang J; Zeng D; Sun H; Rong X; Shi M; Bin J; Liao Y; Liao W
    Cancer Immunol Immunother; 2019 Mar; 68(3):433-442. PubMed ID: 30564892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy.
    Hou LK; Ma YS; Han Y; Lu GX; Luo P; Chang ZY; Xie RT; Yang HQ; Chai L; Cai MX; Wu TM; Yu F; Qin SS; Lv ZW; Wu CY; Fu D
    PLoS One; 2017; 12(1):e0170431. PubMed ID: 28141816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer.
    Holdenrieder S; Von Pawel J; Duell T; Feldmann K; Raith H; Schollen A; Nagel D; Stieber P
    Anticancer Res; 2010 May; 30(5):1855-62. PubMed ID: 20592392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Machine Learning Algorithm Utilization for Lung Cancer Classification Based on Gene Expression Levels.
    Podolsky MD; Barchuk AA; Kuznetcov VI; Gusarova NF; Gaidukov VS; Tarakanov SA
    Asian Pac J Cancer Prev; 2016; 17(2):835-8. PubMed ID: 26925688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-tumoural heterogeneity characterization through texture and colour analysis for differentiation of non-small cell lung carcinoma subtypes.
    Ma Y; Feng W; Wu Z; Liu M; Zhang F; Liang Z; Cui C; Huang J; Li X; Guo X
    Phys Med Biol; 2018 Aug; 63(16):165018. PubMed ID: 30051884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.
    Shiran I; Heller E; Jessel S; Kamer I; Daniel-Meshulam I; Navon R; Urban D; Onn A; Bar J
    Clin Lung Cancer; 2017 May; 18(3):316-323.e1. PubMed ID: 28237243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3-4 NSCLC patients.
    Li C; Tian C; Zeng Y; Liang J; Yang Q; Gu F; Hu Y; Liu L
    BMC Med Genomics; 2022 Feb; 15(1):33. PubMed ID: 35193578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis.
    Xu YH; Zhang GB; Wang JM; Hu HC
    Saudi Med J; 2010 Sep; 31(9):980-6. PubMed ID: 20844808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer.
    Zhu X; Dong D; Chen Z; Fang M; Zhang L; Song J; Yu D; Zang Y; Liu Z; Shi J; Tian J
    Eur Radiol; 2018 Jul; 28(7):2772-2778. PubMed ID: 29450713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL; Ren QG; Wen L; Hu JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies.
    Ou SH; Zell JA
    J Thorac Oncol; 2009 Oct; 4(10):1202-11. PubMed ID: 19701111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.